DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Several companies including PubMatic Inc, TransMedics, PAR Technology Corporation, SI-BONE, Inc, Cytokinetics, Kiniksa Pharmaceuticals, Novavax, Mirum Pharma, Marathon Digital Holdings, Verano, and Trulieve have reported their fourth quarter and fiscal year 2023 financial results. Novavax missed quarterly estimates but narrowed losses, with revenue of $291 million in Q4 and $1 billion for FY'23, providing guidance of $800 million to $1 billion for FY'24.
Verano Announces Fourth Quarter and Full Year 2023 Financial Results $VRNO $VRNOF https://t.co/wOixWnLG49
Trulieve Reports Fourth Quarter and Full Year 2023 Results Highlighting Year End Momentum and Cash Generation $TRUL $TCNNF https://t.co/PDGbqwnQfv
Marathon Digital Holdings Reports Fourth Quarter and Fiscal Year 2023 Results :: Marathon Digital Holdings (MARA) https://t.co/fng9XCbt9E
